Cypilos (Testosterone Cypionate) Driada Medical 250 mg/ml 10ml vial
€ 55,00
- Active ingredient: Testosterone cypionate
- Type: Anabolic steroid (testosterone derivative)
- Form: Injections
- Packaging: 10 ml/vial
- Carrier oil: Sesame oil
Cypilos 250 mg/ml (Testosterone Cypionate) 10ml vial
Testosterone Cypionate is a primary sex hormone found in both men and women. It plays a vital role in the development of reproductive tissues and is responsible for the emergence of secondary sexual characteristics such as increased muscle mass, bone density, and body hair in males. Testosterone also contributes to overall health and prevents conditions such as osteoporosis. Insufficient testosterone levels in men can lead to bone fragility and loss. While known for its anabolic properties, Testosterone Cypionate performs several physiological functions in the body. It is used as hormone replacement therapy for age-related hypogonadism in older adults and as a foundation for athletes during steroid cycles.
Mechanism of Action
Testosterone Cypionate binds to androgen receptors and acts as a precursor to dihydrotestosterone (DHT), a biologically active androgen. DHT is formed through the conversion of testosterone by the enzyme 5α-reductase and has a high binding affinity to androgen receptors. When testosterone or DHT bind to these receptors, they activate signal transmission to the cell nucleus, resulting in changes in gene activity in DNA. Aromatase can also convert testosterone to estrogen, which primarily activates feedback mechanisms that suppress endogenous testosterone production when exogenous testosterone is administered.
Medical Use
Testosterone cypionate is included in the World Health Organization’s List of Essential Medicines for its crucial role in medical treatment. It is used for hormone replacement therapy in conditions such as gender dysphoria, male hypogonadism, and certain types of breast cancer. Hormone replacement therapy ensures testosterone levels remain within normal ranges and helps counteract age-related cognitive decline and sexual dysfunction in adult men.
Testosterone in Sport
Testosterone Cypionate offers significant benefits in sports, primarily in increasing muscle mass and strength. It exhibits both anabolic and androgenic effects by activating androgen receptors in cells. This activation leads to changes in gene expression, promoting muscle growth and improving performance during training. Testosterone Cypionate also improves joint health, helps relieve pain, and stimulates the body’s regeneration processes. Athletes typically use doses between 250 and 500 mg per week, adjusted based on body weight. Cycles typically last 8 to 10 weeks, followed by post-cycle therapy to restore natural hormone production.
Dosages
Beginner: 250 mg per week Medium Dosage: 300-750 mg per week High Dosage: 750+ mg per week
Effects
- Increased muscle mass
- Development of male genitalia and secondary sexual characteristics
- It promotes spermatogenesis and male behavior
- Fat burning
- Increased strength
- Enhanced libido
- Reduction of blood cholesterol levels
- Lower risk of cardiac ischemia and coronary heart disease
- Stimulation of erythropoiesis and distribution of subcutaneous adipose tissue similar to that of males
- Influence on nitrogen and phosphorus metabolism
Side Effects
- Increased blood pressure
- Increased sexual behavior
- Hemoconcentration (blood clotting)
- Possible formation of blood clots in arterial and venous vessels
- Fluid retention (edema)
- Masculinization
- Aggression, agitation, irritability
- Alopecia (baldness of the scalp)
- Acne
- Insomnia (rare)
Profile
- Half-life: 6-8 days
- Frequency of injections: Every 5-7 days
Pharmaceutical Form
Oily solution for intramuscular injection
Contraindications
- Pregnancy
- Known or suspected carcinoma of the prostate or breast
- Breastfeeding
- Hypersensitivity to the active substance or to any of the excipients
Conservation
- Do not use after the expiration date
- Store between 8ºC and 30ºC
- Do not freeze
- Protect from light

Reviews
There are no reviews yet.